Natalie DiMambro is Vice President of Product Commercialization and Training at Within3. Natalie’s career in the pharmaceutical and life sciences industry has included various roles since 2002, beginning with live production and events and landing happily in virtual engagement and software solutions. She is passionate about building deeper relationships in the virtual world and empowering individuals with the technical toolkit and communication skills needed to thrive in the ever-changing life science landscape.
Drug developers need policies and technological infrastructure to execute on their goal of being patient-focused. At a minimum, this means a compliant way to engage patients and truly hear their voices; at its most effective, patient engagement also meets patients where they are – whenever and wherever that may be.
Many pharma and medical device companies will look inward, with the goal of standardizing and modernizing even highly regulated activities. Here’s a closer look at some important industry trends for 2023.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
While Covid-19 temporarily paused our ability to interact face-to-face, it also ushered in an era of global collaboration and the ability for life science teams to make decisions based on an expanded viewpoint.